Terms: = Gastric cancer AND CgA
125 results:
1. Plasma tryptophan pathway metabolites quantified by liquid chromatography-tandem mass spectrometry as biomarkers in neuroendocrine tumor patients.
Johansen SU; Hansen T; Nordborg A; Meyer R; Goll R; Florholmen J; Jensen E
J Neuroendocrinol; 2024 Mar; 36(3):e13372. PubMed ID: 38361341
[TBL] [Abstract] [Full Text] [Related]
2. Biomarkers in neuroendocrine neoplasms.
Zouli C; Zisimopoulou E; Chrisoulidou A
Hell J Nucl Med; 2023; 26 Suppl():44-48. PubMed ID: 37658563
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological features and differential diagnosis of gastric metastases.
Chen W; Liu C; Liu Y; Yuan J; Wang Z
World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological characteristics of gastric adenocarcinoma with enteroblastic differentiation and gastric adenocarcinoma with enteroblastic marker expression.
Abe D; Akazawa Y; Yatagai N; Hayashi T; Ueyama H; Mine S; Fukunaga T; Nagahara A; Yao T; Saito T
Virchows Arch; 2023 Sep; 483(3):405-414. PubMed ID: 37581693
[TBL] [Abstract] [Full Text] [Related]
5. Exploring the molecular characteristics of the malignant potential of gastric adenocarcinoma with enteroblastic differentiation.
Wang Y; Wei X; Ke B; Liu J; Guo Y; Liu Y; Chen Y; Ding T; Wang Y; Meng B; Sun B; Zang F
Histopathology; 2023 Oct; 83(4):631-646. PubMed ID: 37356975
[TBL] [Abstract] [Full Text] [Related]
6. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].
Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354
[No Abstract] [Full Text] [Related]
7. [Clinicopathological characteristics of gastric SMARCA4-deficient undifferentiated/rhabdoid carcinoma].
Wu JY; Jiang K; Yan LJ; Yin LS; Huang XZ; Jia L; Sun Y
Zhonghua Bing Li Xue Za Zhi; 2023 May; 52(5):447-453. PubMed ID: 37106285
[No Abstract] [Full Text] [Related]
8. Expression of 5-HT Relates to Stem Cell Marker LGR5 in Patients with Gastritis and gastric cancer.
Niu Q; Li L; Zhang C; Qi C; He Q; Zhu Y
Dig Dis Sci; 2023 May; 68(5):1864-1872. PubMed ID: 36436157
[TBL] [Abstract] [Full Text] [Related]
9. Chromogranin B in blood serum of patients with neuroendocrine tumors.
Lyubimova NV; Timofeev YS; Markovich AA; Lebedeva AV; Karamisheva EI; Delektorskaya VV; Kushlinskii NE
Klin Lab Diagn; 2022 Aug; 67(8):440-443. PubMed ID: 36095079
[TBL] [Abstract] [Full Text] [Related]
10. A cga/EGFR/GATA2 positive feedback circuit confers chemoresistance in gastric cancer.
Cao T; Lu Y; Wang Q; Qin H; Li H; Guo H; Ge M; Glass SE; Singh B; Zhang W; Dong J; Du F; Qian A; Tian Y; Wang X; Li C; Wu K; Fan D; Nie Y; Coffey RJ; Zhao X
J Clin Invest; 2022 Mar; 132(6):. PubMed ID: 35289315
[TBL] [Abstract] [Full Text] [Related]
11. Clinicopathological and molecular characteristics of the alpha-fetoprotein-producing gastric cancer: emphasis on two major subtypes.
Lu J; Jin M; Zhou X; Chen X; Shao Y; Jiang X
APMIS; 2022 Mar; 130(3):169-180. PubMed ID: 34862662
[TBL] [Abstract] [Full Text] [Related]
12. Anticancer Effects of the
Tosoc JPS; Nuñeza OM; Sudha T; Darwish NHE; Mousa SA
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641577
[No Abstract] [Full Text] [Related]
13. Is Additional Gastrectomy Required for Elderly Patients after Endoscopic Submucosal Dissection with Endoscopic Curability C-2 for Early gastric cancer?
Hatta W; Gotoda T; Koike T; Uno K; Asano N; Imatani A; Masamune A
Digestion; 2022; 103(1):83-91. PubMed ID: 34638125
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic value of different lymph node staging methods for node-positive cardia gastric cancer: a register-based retrospective cohort study.
Wang XQ; Bao M; Zhang C
BMJ Open; 2021 Aug; 11(8):e050378. PubMed ID: 34426469
[TBL] [Abstract] [Full Text] [Related]
15. A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms cga and has surgical and clinical utility.
Modlin IM; Kidd M; Falconi M; Filosso PL; Frilling A; Malczewska A; Toumpanakis C; Valk G; Pacak K; Bodei L; Öberg KE
Ann Oncol; 2021 Nov; 32(11):1425-1433. PubMed ID: 34390828
[TBL] [Abstract] [Full Text] [Related]
16. [Clinicopathological features and survival analysis of gastric cancer patients with neuroendocrine differentiation after radical resection].
Yu S; Lyu MZ; Luo RK; Liu FL; Liu TS
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):426-432. PubMed ID: 34000772
[No Abstract] [Full Text] [Related]
17. Risk factors for progression of appendiceal neuroendocrine tumours: low-stage tumours <5 mm appear to be overwhelmingly indolent and may merit a separate designation.
Noor M; Huber AR; Cates JMM; Gonzalez RS
Histopathology; 2021 Sep; 79(3):416-426. PubMed ID: 33754384
[TBL] [Abstract] [Full Text] [Related]
18. Epstein-Barr Virus Positive gastric cancer: A Distinct Subtype Candidate for Immunotherapy.
Pereira MA; Batista DAM; Ramos MFKP; Cardili L; Ribeiro RRE; Dias AR; Zilberstein B; Ribeiro U; Cecconello I; Alves VAF; Mello ES
J Surg Res; 2021 May; 261():130-138. PubMed ID: 33429221
[TBL] [Abstract] [Full Text] [Related]
19. gastric adenocarcinoma of the fundic gland type: clinicopathological features of eight patients treated with endoscopic submucosal dissection.
Li C; Wu X; Yang S; Yang X; Yao J; Zheng H
Diagn Pathol; 2020 Oct; 15(1):131. PubMed ID: 33097069
[TBL] [Abstract] [Full Text] [Related]
20. Clinicopathological heterogeneity between primary and metastatic sites of gastroenteropancreatic neuroendocrine neoplasm.
Shi H; Jiang C; Zhang Q; Qi C; Yao H; Lin R
Diagn Pathol; 2020 Sep; 15(1):108. PubMed ID: 32917216
[TBL] [Abstract] [Full Text] [Related]
[Next]
